Tibialis Static Lock (TSL™) — Version 1.0: A Dual-Boundary Anchored Isometric Foot Interface for Hemodynamic Support and the Experimental Investigation of Autonomic Coactivation

Tibialis Static Lock (TSL™) — Version 1.0 presents a proposed seated, low-movement physical counter-pressure interface based on a mechanically constrained, dual-boundary foot configuration. In the basic configuration, the heel generates a downward reaction force against a lower boundary while the dorsal forefoot simultaneously generates an upward reaction force against a rigid upper boundary, permitting substantial internal muscular and musculoskeletal loading with minimal visible joint excursion. The work develops the engineering proposition that this dual-boundary anchored isometric configuration may permit controlled recruitment of lower-limb musculature while the user remains seated and externally relatively motionless. It further presents TSL as an experimental platform for investigating whether an intermediate force range may exist in which arterial pressure and/or central hemodynamic support increases while excessive cardiac acceleration is avoided and measurable parasympathetic cardiac modulation remains present. This proposed experimental region is termed the TSL Autonomic Coactivation Window. Version 1.0 distinguishes established physiological principles from TSL-specific hypotheses, defines the proposed mechanical architecture, establishes falsification criteria, and provides a reproducible framework for experimental investigation. No therapeutic efficacy is claimed. TSL is presented as a testable hypothesis and open research platform, not as an established treatment for hypotension, syncope, cardiovascular disease, or autonomic dysfunction. Patent Pending — U.S. Provisional Patent Application No. 64/142,894. Zenodo DOI: 10.5281/zenodo.22140395

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-08-28
DOI
https://doi.org/10.5281/zenodo.22140395
Primary Topic
Diabetic Foot Ulcer Assessment and Management
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Tibialis Static Lock (TSL™) — Version 1.0: A Dual-Boundary Anchored Isometric Foot Interface for Hemodynamic Support and the Experimental Investigation of Autonomic Coactivation

Pavel Pushkin
Zenodo (CERN European Organization for Nuclear Research)
Diabetic Foot Ulcer Assessment and Management
preprint

Tibialis Static Lock (TSL™) — Version 1.0: A Dual-Boundary Anchored Isometric Foot Interface for Hemodynamic Support and the Experimental Investigation of Autonomic Coactivation

Pavel Pushkin
preprint en

Abstract

Tibialis Static Lock (TSL™) — Version 1.0 presents a proposed seated, low-movement physical counter-pressure interface based on a mechanically constrained, dual-boundary foot configuration. In the basic configuration, the heel generates a downward reaction force against a lower boundary while the dorsal forefoot simultaneously generates an upward reaction force against a rigid upper boundary, permitting substantial internal muscular and musculoskeletal loading with minimal visible joint excursion. The work develops the engineering proposition that this dual-boundary anchored isometric configuration may permit controlled recruitment of lower-limb musculature while the user remains seated and externally relatively motionless. It further presents TSL as an experimental platform for investigating whether an intermediate force range may exist in which arterial pressure and/or central hemodynamic support increases while excessive cardiac acceleration is avoided and measurable parasympathetic cardiac modulation remains present. This proposed experimental region is termed the TSL Autonomic Coactivation Window. Version 1.0 distinguishes established physiological principles from TSL-specific hypotheses, defines the proposed mechanical architecture, establishes falsification criteria, and provides a reproducible framework for experimental investigation. No therapeutic efficacy is claimed. TSL is presented as a testable hypothesis and open research platform, not as an established treatment for hypotension, syncope, cardiovascular disease, or autonomic dysfunction. Patent Pending — U.S. Provisional Patent Application No. 64/142,894. Zenodo DOI: 10.5281/zenodo.22140395

Zenodo (CERN European Organization for Nuclear Research)
Diabetic Foot Ulcer Assessment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.